Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.130
+0.110 (3.64%)
At close: Jul 3, 2025, 1:00 PM
3.140
+0.010 (0.32%)
After-hours: Jul 3, 2025, 4:37 PM EDT
Grace Therapeutics Employees
Grace Therapeutics had 6 employees as of March 31, 2025. The number of employees increased by 2 or 50.00% compared to the previous year.
Employees
6
Change (1Y)
2
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$1,594,667
Market Cap
43.28M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GRCE News
- 11 days ago - Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104 - GlobeNewsWire
- 13 days ago - Grace Therapeutics Announces 2025 Fiscal Year-End Results, Provides Business Update - GlobeNewsWire
- 23 days ago - Grace Therapeutics to Participate in the 2025 BIO International Conference - GlobeNewsWire
- 3 months ago - Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104 - GlobeNewsWire
- 4 months ago - Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - GlobeNewsWire
- 4 months ago - Grace Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 5 months ago - Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update - GlobeNewsWire
- 5 months ago - Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study - Benzinga